In this study, the authors sought determine whether microbubble (MB) destruction with pulsed low duty cycle ultrasound can be used to reduce brain tumor perfusion and growth through nonthermal microvascular ablation.
Studies using C57BLJ6/Rag-1 mice inoculated subcutaneously with C6 glioma cells were approved by the institutional animal care and use committee. Microbubbles were injected intravenously, and 1 MHz ultrasound was applied with varying duty cycles to the tumor every 5 seconds for 60 minutes. During treatment, tumor heating was quantified. Following treatment, tumor growth, hemodynamics, necrosis, and apoptosis were measured.
Tumor blood flow was significantly reduced immediately after treatment, with posttreatment flow ranging from 36% (0.00002 duty cycle) to 4% (0.01 duty cycle) of pretreatment flow. Seven days after treatment, tumor necrosis and apoptosis were significantly increased in all treatment groups, while treatment with ultrasound duty cycles of 0.005 and 0.01 inhibited tumor growth by 63% and 75%, respectively, compared with untreated tumors. While a modest duty cycle–dependent increase in intratumor temperature was observed, it is unlikely that thermal tissue ablation occurred.
In a subcutaneous C6 glioma model, MB destruction with low–duty cycle 1-MHz ultrasound can be used to markedly inhibit growth, without substantial tumor tissue heating. These results may have a bearing on the development of transcranial high-intensity focused ultrasound treatments for brain tumors that are not amenable to thermal ablation.
Abbreviations used in this paper: CPS = contrast pulse sequencing; HIFU = high-intensity focused ultrasound; MB = microbubble; TUNEL = terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling.
AyTD'HondtAMPasquetAMelinJAVanoverscheldeJL: Heterogeneity of contrast effect during intermittent second harmonic myocardial contrast echocardiography in healthy patients. J Am Soc Echocardiogr15:1448–14522002
CohenZRZaubermannJHarnofSMardorYNassDZadicarioE: Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model. Neurosurgery60:593–6002007
GeletAChapelonJYPoissonnierLBouvierRRouvièreOCurielL: Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology63:625–6292004
HynynenKClementGTMcDannoldNVykhodtsevaNKingRWhitePJ: 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med52:100–1072004
HynynenKMcDannoldNClementGTJoleszFAZadicarioEKillianyR: Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain—a primate study. Eur J Radiol59:149–1562006
MillerDLLiPDouCGordonDEdwardsCAArmstrongWF: Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology237:137–1432005
PriceRJSkybaDMKaulSSkalakTC: Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation98:1264–12671998
RabinoviciJInbarYRevelAZalelYGomoriJMItzchakY: Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol30:771–7772007
SadlowskiAChomasJPollardRBlochSGriffeySWisnerE: Mean flow rate and integrated perfusion estimates obtained with contrast-assisted ultrasound. IEEE Ultrasonics Symposium2:1977–19802002. (http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1192688) [Accessed November 22 2010]
YehCKKruseDELimMCRedlineDEFerraraKW: A new high frequency destruction/reperfusion system. IEEE Ultrasonics Symposium1:433–4362003. (http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1293439) [Accessed November 22 2010]